Human umbilical cord blood-derived mesenchymal stem cell implantation for osteoarthritis of the knee

被引:30
|
作者
Song, Jun-Seob [1 ]
Hong, Ki-Taek [1 ]
Kim, Na-Min [1 ]
Park, Han-Soo [1 ]
Choi, Nam-Hong [2 ]
机构
[1] Seoul JS Hosp, Dept Orthopaed Surg, Seoul, South Korea
[2] Eulji Med Ctr, Dept Orthopaed Surg, Seoul, South Korea
关键词
Mesenchymal stem cell; Osteroarthritis; Second-look arthroscopy; Umbilical cord blood; HIGH TIBIAL OSTEOTOMY; AUTOLOGOUS CHONDROCYTE IMPLANTATION; CARTILAGE REGENERATION; CLINICAL-TRIAL; REPAIR; HYDROGEL; DEFECTS;
D O I
10.1007/s00402-020-03349-y
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction This study aimed to investigate the clinical outcomes after human umbilical cord blood-derived mesenchymal stem cell (hUCB-MSC) implantation for medial compartment (MC) osteoarthritis of the knee. Materials and methods Inclusion criteria were patients older than 60 years, with a kissing lesion of the MC, a full-thickness chondral defect >= 4 cm(2) of the medial femoral condyle (MFC), and a varus deformity >= 3 degrees on a long cassette scanogram. The mean age was 64.9 +/- 4.4 years and the mean chondral defect of the MFC was 7.2 +/- 1.9 cm(2). A mixture of sodium hyaluronate and hUCB-MSC was implanted into the chondral defect and a high tibial osteotomy was performed in all patients. International Knee Documentation Committee (IKDC), visual analog scale (VAS), and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores were evaluated preoperatively and 1 year and 2 years postoperatively. Cartilage regeneration was evaluated in 14 (56%) patients by second-look arthroscopy at 1 year postoperatively. Results Twenty-five patients underwent hUBC-MSC implantation. IKDC, VAS, and WOMAC scores at 1 year and 2 years improved significantly compared to preoperative scores. These scores at 1 year and 2 years were not significantly different between the body mass index (BMI) < 25 group and BMI >= 25 group. However, the < 65-year-old group showed superior IKDC scores at 1 year and 2 years and VAS score at 2 years than the >= 65-year-old group. Younger age and larger size of the chondral defect were associated with a significantly greater improvement in IKDC, VAS and WOMAC scores at 2 years. Second-look arthroscopy demonstrated International Cartilage Repair Society-Cartilage Repair Assessment grade I in six (42.9%) patients and grade II in eight (57.1%). Conclusions hUCB-MSC implantation regenerated cartilage satisfactorily and showed satisfactory clinical outcomes in patients older than 60 years who had MC osteoarthritis.
引用
收藏
页码:503 / 509
页数:7
相关论文
共 50 条
  • [1] Human umbilical cord blood-derived mesenchymal stem cell implantation for osteoarthritis of the knee
    Jun-Seob Song
    Ki-Taek Hong
    Na-Min Kim
    Han-Soo Park
    Nam-Hong Choi
    Archives of Orthopaedic and Trauma Surgery, 2020, 140 : 503 - 509
  • [2] Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis
    Kangho Suh
    Brian J. Cole
    Andreas Gomoll
    Seung-Mi Lee
    Hangseok Choi
    Chul-Won Ha
    Hong Chul Lim
    Myung Ku Kim
    Gwi-Yeom Ha
    Dong-Churl Suh
    Applied Health Economics and Health Policy, 2023, 21 : 141 - 152
  • [3] High tibial osteotomy with human umbilical cord blood-derived mesenchymal stem cells implantation for knee cartilage regeneration
    Song, Jun-Seob
    Hong, Ki-Taek
    Kong, Chae-Gwan
    Kim, Na-Min
    Jung, Jae-Yub
    Park, Han-Soo
    Kim, Young Ju
    Chang, Ki Bong
    Kim, Seok Jung
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (06): : 514 - 526
  • [4] Human umbilical cord blood-derived mesenchymal stem cell transplantation for the treatment of spinal cord injury
    Cui, Bingzhou
    Li, En
    Yang, Bo
    Wang, Bo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (05) : 1233 - 1236
  • [5] Human umbilical cord blood-derived mesenchymal stem cells and their effect on gliomas
    Shankar, S. K.
    NEUROLOGY INDIA, 2011, 59 (02) : 226 - 228
  • [6] Efficient transfection of human umbilical cord blood-derived mesenchymal stem cells and multiple stem cell traits
    Lim, J. Y.
    Jeong, C. H.
    Oh, J. H.
    Park, S. I.
    Kim, S. M.
    Oh, W.
    Jeun, S. -S.
    Park, S. A.
    Park, S. H.
    CELL TRANSPLANTATION, 2008, 17 (04) : 472 - 472
  • [7] Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
    Li, Zepeng
    Zhou, Xiaoling
    Han, Lu
    Shi, Meijie
    Xiao, Huanming
    Lin, Ming
    Chi, Xiaoling
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (05) : 926 - 931
  • [8] Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
    Zepeng Li
    Xiaoling Zhou
    Lu Han
    Meijie Shi
    Huanming Xiao
    Ming Lin
    Xiaoling Chi
    Journal of Gastrointestinal Surgery, 2023, 27 : 926 - 931
  • [9] Human Umbilical Cord Blood-Derived Stromal Cells Are Superior to Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Inducing Myeloid Lineage Differentiation In Vitro
    Sun, Hao-Ping
    Zhang, Xi
    Chen, Xing-Hua
    Zhang, Cheng
    Gao, Lei
    Feng, Yi-Mei
    Peng, Xian-Gui
    Gao, Li
    STEM CELLS AND DEVELOPMENT, 2012, 21 (09) : 1429 - 1440
  • [10] In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells
    Gang, EJ
    Hong, SH
    Jeong, JA
    Hwang, SH
    Kim, SW
    Yang, IH
    Ahn, CY
    Han, H
    Kim, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 102 - 108